Episode Details

Back to Episodes
#64 IP Protection in the Life Sciences Industry

#64 IP Protection in the Life Sciences Industry

Published 6ย months, 3ย weeks ago
Description
Featured content by Christian Heubeck: IP is a crucial economic engine for the life sciences industry

This sector, encompassing biotechnology, pharmaceuticals, and medical devices, faces high development costs, long timelines, and significant risks when bringing innovations to market. Patents offer a limited-time monopoly, allowing companies to recoup massive research and development investments and fund future discoveries. This episode underscores how IP acts as the economic engine for this industry, encouraging innovation and attracting necessary investment.

Show Notes ๐Ÿ“Œ Here you can find the IP protection in the life sciences industry page by Dr. Christian Heubeck on the digital IP lexicon ๐Ÿ”—๐—ฑ๐—œ๐—ฃ๐—น๐—ฒ๐˜… ๐Ÿ‘‰ Link

๐Ÿ“Œ Please note the current **Call for Subject Matter Experts **for the IP Business Academy 2025: ๐Ÿ‘‰ Link

๐Ÿ“Œ Here you can find the newsletter ๐ŸŽฏ๐—œ๐—ฃ ๐— ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ฃ๐˜‚๐—น๐˜€๐—ฒ which reports every 14 days on the most important news worldwide in IP and IP management: ๐Ÿ‘‰ Link

๐Ÿ“Œ The newsletter ๐ŸŽฏ๐—œ๐—ฃ ๐— ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ฃ๐˜‚๐—น๐˜€๐—ฒ also has an archive of all previous issues in which you can research topics, which you can find here: ๐Ÿ‘‰ Link

๐Ÿ“Œ In the ๐Ÿ”Ž๐—œ๐—ฃ ๐— ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—š๐—น๐—ผ๐˜€๐˜€๐—ฎ๐—ฟ๐˜† you will find all the important terms of IP management explained in detail including audio summaries for each term: ๐Ÿ‘‰ Link

๐Ÿ“Œ If you would like to learn more about personal growth topics for IP experts such as digital marketing, business development, etc., then visit our ๐ŸŒฑ Resource Hub: ๐Ÿ‘‰ Link

๐Ÿ“Œ Here you can find IP Subject Matter Expert Dr. Christian Heubeck on LinkedIn: ๐Ÿ‘‰ Link

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us